Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy consisting of four components—vitamin C (ascorbic acid), glucose, insulin, and potassium. Each component has a distinct mechanism of action: - **Vitamin C** acts as an antioxidant and cofactor in enzymatic reactions. - **Glucose** serves as a primary energy substrate for cells. - **Insulin** is a peptide hormone that facilitates cellular uptake of glucose and regulates carbohydrate metabolism. - **Potassium** is an essential electrolyte involved in nerve conduction, muscle contraction, and cellular homeostasis. This combination does not correspond to any single approved pharmaceutical product or brand but may be used together in specific clinical scenarios such as the management of severe hyperkalemia (where insulin with glucose helps shift potassium into cells) or certain metabolic emergencies. The addition of vitamin C is less common but may be considered for its antioxidant properties or to address deficiency. The mixture must be administered under medical supervision due to risks like hypoglycemia (from insulin), hyperglycemia (from excess glucose), or electrolyte imbalances.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitamin c + glucose + insulin + potassium.